A081801
OPEN TO ACCRUAL
PhIII Study of Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC
A151216
OPEN TO ACCRUAL
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
EA8191
OPEN TO ACCRUAL
Ph III - Therapy Intensification for Prostate Cancer Pts with Post-Prostatectomy Biochem Recurrence
EAA181
OPEN TO ACCRUAL
Ph III Trial for Newly Diagnosed Multiple Myeloma Not Intended For Early Autologous Transplantation